NCT05806151View on ClinicalTrials.gov

Prediction of True Oligo-metastatic Disease.

RecruitingOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Oligometastatic Disease
Interventions
DIAGNOSTIC_TEST

Genetic and immunologic assessments

Definitive Local Therapies including surgery, radiotherapy, radio-frequency ablation of metastases.

Trial Locations (1)

80131

RECRUITING

Alessandro Ottaiano, Naples

All Listed Sponsors
lead

National Cancer Institute, Naples

OTHER